Related by context. All words. (Click for frequent words.) 78 HCV protease inhibitor 71 class oral heparinoid 70 Sulonex TM previously 70 lexidronam injection 69 myelofibrosis polycythemia vera 69 virus HCV protease inhibitor 69 non nucleoside inhibitor 69 Tekmira LNP technology 68 MT# MEDI 68 AN# systemic antibiotic 68 ALN HPN 68 MAGE A3 ASCI 67 targeted radiotherapeutic 67 delivers fluocinolone acetonide FA 67 stable nucleic acid 67 HCV NS5B polymerase 67 orally administered inhibitor 67 Ovitrelle R Serostim 67 TACI Ig 67 oral nucleoside analogue 67 MKC# MKC# PP 66 samarium Sm 66 pan HDAC inhibitor 66 familial amyloidotic polyneuropathy FAP 66 Mg Usa 66 BLP# Liposome Vaccine 66 ketolide antibiotic 66 INSPIRE Trial Phase III 66 huC# DM4 66 phase III isavuconazole 65 thymalfasin 65 AAG geldanamycin analog 65 alpha folate receptor 65 dasatinib Sprycel ® 65 histone deacetylase HDAC inhibitor 65 novel VDA molecule 65 Polymerase Inhibitor 65 Iluvien ® 65 mertansine 65 diarrhea predominant irritable 65 GW# [003] 65 ALN PCS 65 Tezampanel 65 MKC# MT 65 Methylnaltrexone 65 Sudhir Agrawal D.Phil 65 Mg Uk 65 trastuzumab Herceptin R 65 thiazolides 65 luteinizing hormone releasing 65 PSMA ADC 64 SinuNase ™ 64 CYT# potent vascular disrupting 64 Zorbtive TM 64 metaglidasen 64 BCG refractory carcinoma 64 IgG1 monoclonal antibody 64 PEG SN# 64 PDX pralatrexate 64 phase IIb clinical 64 GSK '# 64 essential thrombocythemia ET 64 IMiDs R 64 Solazed TM 64 investigational humanized monoclonal antibody 64 mGluR5 negative 64 AEG# 64 CD4 monoclonal antibody 64 docetaxel Taxotere R 64 transthyretin mediated amyloidosis ATTR 64 RhuDex ® 64 XL# XL# XL# 64 polymerase inhibitor 64 toenail onychomycosis 64 vapreotide acetate 64 intravesical infusion therapy 64 receptor tyrosine kinase inhibitor 63 selective androgen receptor modulators 63 MEK inhibitor 63 NS5b 63 Onco TCS 63 lintuzumab SGN 63 sorafenib tablets 63 pralatrexate injection folate analogue 63 castrate resistant prostate cancer 63 Cytogen marketed 63 ocular formulation 63 recombinant subunit vaccine 63 Phase Ib clinical trials 63 nucleoside analog 63 GRNOPC1 contains 63 generation antisense inhibitor 63 acetonide FA 63 TASKi2 63 proteasome inhibitor 63 lesinurad 63 investigational monoclonal antibody 63 sunitinib Sutent ® 63 XL# anticancer compounds 63 Aurora kinase inhibitor 63 PNP inhibitor 63 PROSTASCINT R 63 secretory phospholipase A2 63 lexidronam injection PROSTASCINT 63 refractory chronic lymphocytic 63 IMA# 63 elotuzumab 63 Ozarelix 63 IMiDs ® compound 63 triciribine phosphate monohydrate 63 trastuzumab DM1 T DM1 63 dextromethorphan quinidine 63 oral prodrug 63 topically applied SEPA 63 Elvitegravir 63 TRANSDUR ® 63 Zenvia ™ 63 generation HCV protease 63 IAP inhibitor 63 refractory gout 63 CCR5 antagonist 63 GSK# [001] 63 memantine HCl 63 oral dihydropyrimidine dehydrogenase DPD 63 interferon gamma 1b 63 dyskinesia PD LID 63 BUPHENYL 63 systemic RNAi therapeutic 63 cetuximab Erbitux R 63 VISICOL R 63 CDK cyclin dependent 63 Ridaforolimus 63 evaluating T DM1 63 topical gel formulation 63 vinca alkaloid 63 sulfonylhydrazine class 63 FOLOTYN ® 62 CYP#A# CYP#D# 62 HCV polymerase inhibitors 62 gefitinib Iressa 62 developing Bicifadine serotonin 62 SPL# Gel vaginal microbicide 62 mg q#h 62 K ras mutations 62 hypoxia selective 62 gastrin analogue TT 62 Daclizumab 62 HDAC Inhibitor 62 2 inhibitor CYT# 62 modified glutathione analog 62 oral ridaforolimus 62 JAK inhibitor 62 Medidur ™ FA 62 humanized monoclonal antibody 62 Liprotamase 62 selective androgen receptor modulator 62 Panzem R 62 Alfacell proprietary ribonuclease 62 liposomal formulation 62 gastrointestinal disorders ATI 62 RTP #i 62 5 HT2A inverse 62 Empatic ™ 62 MKC# 62 relapsed refractory multiple myeloma 62 etanercept Enbrel 62 YONDELIS 62 pan histone deacetylase 62 non nucleoside HCV 62 Saxagliptin 62 Peginterferon alfa 2b 62 thalidomide Thalomid 62 Personalized Immunotherapy 62 telaprevir VX 62 arsenic trioxide injection 62 IMiDs ® 62 myelodysplastic myeloproliferative diseases 62 Prodarsan R 62 Eltrombopag 62 Navelbine ® 62 Silodosin 62 T#I [002] 62 INC# 62 AAG KOS 62 ENMD # 62 midstage clinical 62 recurrent glioblastoma multiforme 62 ADP receptor antagonist 62 investigational oral hepatitis C 62 prasugrel CS 62 Zolinza 62 posaconazole 62 anti CD3 monoclonal 62 N acetylgalactosamine 6 62 Telaprevir VX 62 Traficet EN 62 erlotinib Tarceva ® 62 Voreloxin 62 agonistic human 62 Aflibercept 62 oral ghrelin agonist 62 leading oral taxane 62 topical antifungal product 62 Xeloda ® 62 docetaxel Taxotere ® 62 hormone LHRH antagonist 62 beta 1a 62 INFeD R 62 prokinetic agent 62 Kuvan sapropterin dihydrochloride 62 LY# [003] 62 mg RDEA# 61 PEGylated Fab fragment 61 CCX# 61 RhuDex TM 61 PrevOnco 61 Aurexis 61 MT#/MEDI-# 61 cell lymphoma CTCL 61 Ostarine ™ 61 novel topoisomerase 61 generation Hsp# inhibitor 61 octreotide acetate 61 Ceflatonin R 61 Kinase Inhibitor 61 Degarelix 61 gastrointestinal stromal tumors 61 Ixempra 61 sodium glucose cotransporter 61 PS# [001] 61 candidate AQ4N 61 PDE4 inhibitor 61 Pruvel ™ 61 bevacizumab Avastin ® 61 LY# [002] 61 Vicriviroc 61 ALN TTR 61 AzaSite Plus 61 Veronate R 61 Oral NKTR 61 MORAb 61 ALGRX 61 Solazed ™ 61 plasma kallikrein inhibitor 61 KNS # 61 Hedgehog Pathway Inhibitor 61 protein tyrosine phosphatase 1B 61 ThermoDox ® clinical 61 TBC# 61 Dapagliflozin 61 INTEGRILIN 61 μg dose 61 TNF Tumor Necrosis Factor 61 transcriptase inhibitor NNRTI 61 Zemiva TM 61 multicenter Phase II 61 Sutent sunitinib malate 61 Proellex TM 61 Elotuzumab 61 markets COLAZAL 61 candidate custirsen 61 Telik logo TELINTRA 61 CEQ# 61 Phase 2b Clinical Trial 61 TRO# 61 Copegus ribavirin 61 adalimumab Humira 61 nucleotide analogue 61 evaluating picoplatin 61 Rigel R# 61 virus HCV infection 61 Azedra ™ 61 RELOVAIR ™ 61 kidney urologic 61 2 methoxyestradiol 61 Luveris R Ovidrel R 61 Oracea TM 61 metastatic hormone refractory 61 vinorelbine tartrate 61 OncoVex 61 TLK# 61 delta opioid receptor 61 Epratuzumab 61 CCR5 mAb 61 CD3 monoclonal antibody 61 investigational hepatitis C 61 YOUR LOCAL ANIMAL SHELTER 61 OMP #R# 61 generation antisense 61 vascular disrupting agents VDAs 61 sarcoma melanoma 61 R sorafenib tablets 61 Aztreonam lysine 61 humanized anti 61 ILUVIEN ® 61 Dacogen injection 61 cancer indications bafetinib 61 SAR# [004] 61 THR beta agonist 61 multi kinase inhibitor 61 Meets Primary Endpoint 61 Trastuzumab DM1 61 PORxin TM platforms 60 iobenguane 60 IL# PE#QQR 60 allosteric modulator NAM 60 investigational HCV polymerase 60 Nexavar sorafenib 60 candidate XP# 60 MEK Inhibitor 60 hypereosinophilic syndrome 60 inhaled formulation 60 Phase III Pivotal 60 octreotide implant 60 Ecallantide 60 PET FROM 60 M2 subunit 60 Omnitarg 60 IMPDH inhibitor 60 Zemiva ™ 60 Epivir 60 pentadentate logo R 60 Albugon 60 bevacizumab Avastin R 60 5 fluorouracil leucovorin 60 Uricase PEG 60 nalbuphine ER 60 candidate REP# 60 SPRYCEL ® 60 Bezielle 60 Talabostat 60 oncolytic virus therapies 60 Pemetrexed 60 MAXY alpha 60 HCV protease 60 CD# monoclonal antibody 60 investigational immunotherapy 60 c Raf kinase 60 Pharma Merck Serono 60 Parkinson disease levodopa induced 60 evaluating satraplatin 60 Completes Patient Enrollment 60 oral proteasome inhibitor 60 investigational compounds 60 MPS IVA 60 PF # [002] 60 Prodarsan ® 60 inhibitor RG# 60 fosbretabulin 60 Crofelemer budesonide foam 60 Safinamide 60 TELINTRA 60 humanised monoclonal antibody 60 VQD 60 CYT# QbG# 60 class anticancer quinolone 60 Fx #A 60 solithromycin 60 integrin inhibitor 60 delivered RNAi therapeutic 60 HepeX B TM 60 VEGFR2 inhibitor 60 intranasal formulation 60 Vicinium TM 60 Genasense ® oblimersen 60 Hos2 60 Sapacitabine 60 Aurora kinase 60 chronic HCV infection 60 TKB# 60 Fibrillex TM 60 dihydrochloride Tablets 60 R roscovitine 60 measurable tumor regressions 60 Aliskiren 60 phase IIb trial 60 Hydrochlorothiazide Tablets 60 DEB# 60 PEGylated anti 60 candesartan cilexetil 60 reslizumab 60 Metastatic Melanoma 60 telomerase therapeutic 60 cutaneous T 60 Homspera TM 60 4SC AG ISIN DE# 60 peptibody 60 ALN TTR# 60 Xcytrin R 60 SAR# [002] 60 phase Ib clinical 60 vascular occlusive diseases 60 IMiD 60 CD# CEA 60 huN# DM1 60 Alocrest 60 Enzastaurin 60 Familial Adenomatous Polyposis FAP 60 ATL# [001] 60 metastatic castration resistant 60 Pharmos proprietary 60 HMG CoA reductase inhibitors 60 XOMA 3AB 60 compound INCB# 60 myeloproliferative disorders 60 Velcade bortezomib 60 PRTX 60 anti PlGF 60 albiglutide 60 tumor xenograft models 60 inhalation aerosol 60 brivanib 60 MGd 60 JZP 60 compound AEZS 60 polymerase inhibitors 60 Romiplostim 60 PI3K/Akt pathway inhibitor 60 Janus Kinase 60 Initiates Clinical Trial 60 castration resistant prostate cancer 60 imatinib Gleevec ® 60 Lenocta 60 drug conjugate 60 Phase #b/#a clinical 60 forodesine 60 P#X# antagonist 60 alvespimycin 60 apoptosis proteins 60 PARP inhibitor 59 Ceflatonin 59 Submits NDA 59 Nanobody 59 Provectus Pharmaceuticals specializes 59 Gammagard Liquid 59 VentiRx Pharmaceuticals 59 modulator SERM 59 Phase Ib study 59 investigational antiplatelet agent 59 sapacitabine CYC# 59 Irinotecan 59 Nexavar ® 59 pharmacogenetic test 59 treat chronic sinusitis 59 Novartis Trileptal 59 GSK# [002] 59 IMiDs 59 Cloretazine 59 irinotecan doxorubicin oxaliplatin paclitaxel 59 Xanafide 59 Tyrima 59 5 FU leucovorin 59 long acting muscarinic 59 oral Azacitidine 59 nilotinib Tasigna ® 59 Hsp# Inhibitor 59 Epothilone D 59 ATRA IV 59 AEGR 59 VitiGam 59 Motavizumab 59 brivaracetam 59 Initiates Phase II 59 relapsed leukemia 59 PSN# [002] 59 SUTENT ® 59 oral Janus kinase 59 IRX 2 59 factor Xa 59 Granted Orphan Drug 59 HQK 59 LymphoStat B TM 59 aripiprazole Abilify 59 Genentech Rituxan 59 systemically administered 59 Intermezzo ® zolpidem tartrate 59 UPLYSO 59 Solazed 59 Luteinizing Hormone Releasing Hormone 59 Lenocta TM 59 sertraline Zoloft 59 TLR9 agonists 59 PEGylated interferon beta 1a 59 receptor modulators 59 BCR ABL inhibitors 59 sunitinib malate 59 Factor VIIa 59 sPLA2 59 Atrasentan 59 PRT# 59 R MSCRAMM 59 CTA# Injection 59 Cyclooxygenase Inhibiting Nitric Oxide 59 RhuDex R 59 DPP4 inhibitor 59 ARC# [002] 59 CTAP# Capsules 59 evaluating tivozanib 59 Reverset 59 dimebon latrepirdine 59 aurora kinase 59 investigational pan BCR 59 poly ADP ribose polymerase 59 R#/MEM # 59 Hycamtin 59 Proxinium TM 59 IPL# 59 lipid nanoparticle 59 antibody MAb 59 Actonel risedronate 59 adecatumumab MT# 59 Onalta 59 CR# vcMMAE 59 Randomized Phase 59 Investigational Oral 59 acyclovir Lauriad R 59 Pruvel TM 59 HCV polymerase 59 topical ophthalmic 59 TLR7 agonist 59 Onalta ™ 59 multicenter Phase III 59 receptor inhibiting monoclonal 59 tiapamil 59 Teriflunomide 59 INxin TM 59 selective phosphodiesterase 59 Mipomersen 59 hyaluronidase enzyme 59 lorvotuzumab mertansine 59 Aplidin R 59 Omacetaxine 59 Piperacillin 59 compound PMX # 59 BMS # 59 epothilones 59 pradefovir 59 JAK2 Inhibitor 59 Boceprevir 59 markets Testim ® 59 JAK1 59 Trofex ™ 59 5 HT6 59 Amrubicin 59 ZACTIMA 59 fostamatinib disodium 59 Receives Fast Track 59 Dasatinib 59 HCD# [002] 59 product candidate Lpathomab 59 Guanilib 59 PNT# 59 dihydrochloride 59 Tarceva TM 59 IV Busulfex 59 novel synthetic peptide 59 XL# XL# 59 prostate cancer AIPC 59 OMNARIS HFA 59 NS#/#A protease 59 MSCRAMM ® 59 metastatic malignant 59 Dick Thornburgh Sica 59 dacetuzumab SGN 59 rNAPc2 59 CRx 59 GVAX ® 59 pertuzumab 59 Cannabinor 59 anticancer compound 59 antisense inhibitors 59 Panzem 59 TKM ApoB 59 echinocandin 59 Phase 2a Clinical Trial 59 Zarnestra 59 drug pipeline TAFA# 59 CYC# 59 hypoxia activated prodrug 59 tasocitinib 59 reversible inhibitor 59 Ocrelizumab 59 essential thrombocythemia 59 anti botulism antibody 58 alkylating agent 58 DOS# 58 Hematide ™ 58 PLK1 SNALP 58 Lexapro Effexor Serzone 58 clozapine Clozaril 58 corticosteroid dexamethasone 58 enzastaurin 58 REGN# 58 Androxal TM 58 stage antibody MT# 58 CIMZIA TM 58 Quinamed R 58 Drug Candidate 58 antisense oligonucleotide 58 cyclophilin inhibitor 58 Cetrorelix 58 rHuPH# recombinant human 58 inflammatory autoimmune diseases 58 CCX# B 58 Phase IIa trials 58 molecular imaging radiopharmaceutical 58 refractory multiple myeloma 58 Carfilzomib 58 XP# XP# 58 Medoxomil 58 Trofex TM 58 carcinoid syndrome 58 monoclonal antibody conjugated 58 DermaVir Patch 58 Lubiprostone 58 Phenoptin 58 HCV nucleotide polymerase inhibitor 58 Kahalalide F 58 proprietary BiTE ® 58 novel histone deacetylase 58 pan BCR ABL 58 PANVAC VF 58 Ophena TM 58 AstraZeneca Symbicort 58 volociximab 58 Phase IIb clinical trials 58 RNAi therapeutic targeting 58 Nventa proprietary CoVal 58 phase IIb study 58 Pimavanserin 58 HGS ETR1 mapatumumab 58 ToGA 58 Budesonide foam crofelemer 58 Phase 1b clinical trials 58 Ixabepilone 58 oral candidiasis 58 radezolid 58 mitogen activated ERK kinase 58 selective estrogen receptor modulator 58 AKT inhibitor 58 apricitabine ATC 58 Arno Therapeutics 58 Sustiva efavirenz 58 Roche Pegasys 58 Dacogen decitabine 58 midstage trials 58 candidate ATHX 58 DiLA2 58 Temsirolimus 58 GRNVAC1 58 IAP inhibitors 58 myeloproliferative neoplasms 58 HuMax HepC TM 58 HuLuc# 58 ongoing Phase 1b 58 Afinitor everolimus 58 candidate bevirimat PA 58 ceroid lipofuscinosis NCL 58 INCB# [001] 58 Troxatyl 58 TORISEL 58 NS4A 58 Friedreich Ataxia FRDA 58 tanespimycin 58 EndoTAG 58 Cariprazine 58 Levaquin levofloxacin 58 AKIP ™ 58 anti amnesic 58 EGFR HER2 58 TRIOLEX ™ 58 chemotherapy induced neutropenia 58 RAV# 58 Cethromycin 58 RNAi Therapeutic 58 sorafenib Nexavar 58 sulodexide 58 EndoTAG TM -1 58 Adecatumumab 58 IV acetaminophen 58 Cloretazine ® 58 BAY #-# 58 protein kinase inhibitor 58 Locteron ® 58 Glucophage XR 58 treat refractory angina 58 LHRH antagonist 58 CRTH2 58 sodium Injection 58 fostamatinib 58 Zalypsis 58 chronic eosinophilic leukemia 58 highly selective inhibitor 58 RAS MAPK pathway 58 TASKi3 58 visilizumab 58 developing Zerenex TM 58 microtubule inhibitor 58 gemcitabine cisplatin 58 ZADAXIN ® 58 selective modulator 58 Entereg R 58 orally bioavailable 58 Pertuzumab 58 paclitaxel Taxol 58 generation purine nucleoside 58 anti CD3 antibody 58 HCV RNA polymerase 58 Trandolapril 58 3 registrational trial 58 RGB # 58 PD LID 58 NU# direct 58 metastatic RCC 58 selective immunoproteasome inhibitor 58 Cytochrome P# 58 Anticalin R 58 antibody MT# 58 XL# XL# XL# XL# 58 FOLFOX6 chemotherapy regimen 58 Bicalutamide 58 Orphan Drug designations 58 Sym# 58 selective antagonist 58 CDK inhibitor 58 valsartan Diovan 58 Torisel 58 EVIZON TM squalamine lactate 58 including eniluracil ADH 58 imatinib mesylate 58 Amigal TM 58 Azedra TM 58 CCR9 antagonist 58 oral picoplatin 58 zanolimumab 58 Tesetaxel 58 glucagon receptor 58 drug conjugate ADC 58 ATL# [002] 58 Azedra 58 oral kinase inhibitor 58 Dalbavancin 58 Janus kinase 58 initiate Phase 1b 58 KB# [002] 58 Levoleucovorin 58 metastatic carcinoid 58 TELCYTA 58 immunomodulating 58 histone deacetylase inhibitor 58 ziprasidone Geodon 58 EXECUTIVE SUMMARY II 58 HIV treatments Reyataz 58 dirucotide 58 beta2 agonist 58 Nanobody R 57 dexpramipexole 57 paroxetine Paxil 57 Through Glycoscience R 57 CYT# vascular disrupting 57 Poly ICLC 57 Pivotal Phase III 57 Civacir 57 human C1 inhibitor 57 Desvenlafaxine 57 Aganocide 57 mapatumumab 57 metastatic castrate resistant 57 pomalidomide 57 diabetic neuropathic pain 57 Plicera 57 Corlux 57 TG# [003] 57 Gilead Viread 57 Zalbin 57 TRX1 57 JAK inhibitors 57 muraglitazar 57 Evoltra ® 57 gastrointestinal stromal tumor GIST 57 Apixaban 57 Romidepsin 57 omecamtiv mecarbil formerly 57 MTP inhibitor 57 cholesteryl ester transfer 57 Xyfid TM 57 Emtriva emtricitabine 57 virus AAV 57 pharmacogenomic translational research 57 Pharmacokinetics PK 57 Asentar TM 57 tolevamer 57 Phase 2b Trial 57 Phase Ib clinical 57 hyperphenylalaninemia HPA due 57 mg TID 57 MCSP respectively 57 Muraglitazar 57 Kosan dependence 57 metastatic renal cell 57 Tarmogen 57 ara C 57 Vinorelbine 57 hepatitis C polymerase inhibitor 57 Epirubicin 57 targeted antifolate 57 oral Hsp# inhibitor 57 KSP inhibitor 57 histone deacetylase HDAC inhibitors 57 Initiate Phase 57 targeting CD# 57 infliximab Remicade 57 Clin Chem 57 Evgeny Novikov Mitsubishi Lancer 57 HIV integrase inhibitor 57 DDP# 57 cortisol synthesis 57 Initiates Enrollment 57 Boliker repeatedly 57 Spiegelmer ® 57 XmAb# 57 controlled multicenter Phase 57 mGluR5 NAM 57 plus Copegus R 57 angiogenesis inhibitor 57 Vitaxin 57 peptidic compound 57 personalized cellular immunotherapy 57 PKC# 57 Rilonacept 57 antisense drug 57 peripherally acting 57 terlipressin 57 methionine aminopeptidase 57 psoriasis rheumatoid arthritis 57 alvimopan 57 transthyretin TTR 57 Lu AA# 57 TLR9 agonist 57 Aurora Kinase 57 nucleotide analog 57 Solorel TM 57 development peramivir neuraminidase 57 Panzem NCD 57 nephropathic cystinosis 57 Proleukin 57 stage IIIB 57 * Azixa 57 somatostatin analogue 57 Aztreonam 57 myeloproliferative diseases 57 candidate FAV 57 XYOTAX TM 57 androgen receptor modulator 57 radiation sensitizer 57 regorafenib 57 Aviptadil 57 leukemia AML 57 Bevacizumab 57 Anidulafungin 57 mTOR inhibitor 57 tafamidis 57 Gleevec resistant 57 inhibit oxidative stress 57 investigational protease inhibitor 57 world safest multivalent 57 Vandetanib 57 refractory CLL 57 PORxin TM 57 Junovan TM 57 cutaneous T cell 57 romidepsin novel 57 ZEVALIN ® 57 developing ACAPODENE 57 Commences Phase 57 oral Factor Xa 57 LUCK Happy Birthday 57 Monopril 57 Bosutinib 57 R vancomycin hydrochloride 57 JVRS 57 humanized monoclonal 57 TRIOLEX HE# APOPTONE HE# 57 Phase IIa clinical trials 57 By JAMAAL ABDUL 57 Azacitidine 57 mesylate 57 ceftazidime 57 TRISENOX ® 57 cMET 57 lumiliximab 57 Tasigna nilotinib 57 PTH analogue 57 Immunotherapeutic 57 depsipeptide 57 irreversible inhibitor 57 Anticancer Compound 57 novel L DOS# 57 haloperidol Haldol 57 Contrave# 57 DB# [003] 57 novel emulsion formulation 57 intravenously administered 57 Aplidin 57 Tasimelteon 57 FLT3 57 GSK # 57 conjugated estrogens 57 HIV RDEA# 57 selective kinase inhibitor 57 Tocilizumab 57 docetaxel Taxotere 57 Zenvia TM 57 accumulate preferentially 57 photodynamic therapy PDT 57 sargramostim 57 Eraxis 57 ZFNs clinical trials 57 Vilazodone 57 fondaparinux sodium 57 ELACYT 57 taxane resistant 57 Iloperidone 57 TELINTRA R 57 busulfan 57 Merck OSI Pharmaceuticals 57 malignant mesothelioma Alfacell 57 administered subcutaneously 57 BRIM2 57 cathepsin K inhibitor 57 trastuzumab DM1 57 Aganocide ® 57 generation URAT1 inhibitor 57 romazarit 57 Shigamabs ® 57 novel immunomodulatory 57 KRYSTEXXA TM pegloticase 57 MVA HPV IL2 57 Aranesp darbepoetin alfa 57 Pruvel 57 Taxotere docetaxel 57 Acute Myeloid Leukemia AML 57 Miacalcin 57 LAF# 57 dasatinib Sprycel 57 DNA RNA Medicines 57 pheochromocytoma 57 albinterferon alfa 2b 57 Clevudine 57 BIM #A# 57 amifampridine phosphate 56 biodefense pathogens 56 HGS ETR2 56 miconazole Lauriad R 56 renin inhibitors 56 DMAG 56 Antibody Drug Conjugate 56 subcutaneous PRO 56 mda 7 56 neratinib 56 transthyretin TTR mediated amyloidosis 56 XmAb ® 56 AEZS 56 Zybrestat 56 Locked Nucleic Acid LNA 56 novel therapeutic antibodies 56 non cirrhotic portal 56 ALTU 56 clinical trials lintuzumab SGN 56 fluoropyrimidine 56 CRLX# 56 galiximab 56 aerosolized AAT 56 tenofovir Viread 56 BRAF inhibitor 56 Ambrisentan 56 MVA BN R 56 Vertex hepatitis C 56 EZN 56 DORIBAX 56 ALN VSP 56 naproxen esomeprazole magnesium 56 initiated Phase Ib 56 AstraZeneca PLC Accolate 56 VA# [002] 56 mGluR2 positive 56 atrasentan 56 developing ostarine selective 56 alefacept 56 CDP# 56 Topline Results 56 Merck Serono Nycomed 56 Vaprisol 56 leukemia CLL 56 selective adenosine 56 tipifarnib 56 lenalidomide Revlimid 56 candidates bavituximab 56 Pradefovir